These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22460416)

  • 1. Possible role of adipokines in systemic lupus erythematosus and rheumatoid arthritis.
    Barbosa Vde S; Rêgo J; Antônio da Silva N
    Rev Bras Reumatol; 2012; 52(2):278-87. PubMed ID: 22460416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors.
    Vadacca M; Margiotta D; Rigon A; Cacciapaglia F; Coppolino G; Amoroso A; Afeltra A
    J Rheumatol; 2009 Feb; 36(2):295-7. PubMed ID: 19132788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of adipokines in systemic lupus erythematosus.
    Li HM; Zhang TP; Leng RX; Li XP; Li XM; Liu HR; Ye DQ; Pan HF
    Immunol Res; 2016 Aug; 64(4):820-30. PubMed ID: 27314594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity.
    Stofkova A
    Endocr Regul; 2009 Oct; 43(4):157-68. PubMed ID: 19908934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin: a biomarker for rheumatoid arthritis?
    Chen X; Lu J; Bao J; Guo J; Shi J; Wang Y
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):83-9. PubMed ID: 22910140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis.
    Derdemezis CS; Filippatos TD; Voulgari PV; Tselepis AD; Drosos AA; Kiortsis DN
    Fundam Clin Pharmacol; 2009 Oct; 23(5):595-600. PubMed ID: 19563510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokine interactions promote the pathogenesis of systemic lupus erythematosus.
    Chougule D; Nadkar M; Venkataraman K; Rajadhyaksha A; Hase N; Jamale T; Kini S; Khadilkar P; Anand V; Madkaikar M; Pradhan V
    Cytokine; 2018 Nov; 111():20-27. PubMed ID: 30098476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
    Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.
    Otero M; Lago R; Gomez R; Lago F; Dieguez C; Gómez-Reino JJ; Gualillo O
    Ann Rheum Dis; 2006 Sep; 65(9):1198-201. PubMed ID: 16414972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines as novel biomarkers in paediatric systemic lupus erythematosus.
    Al M; Ng L; Tyrrell P; Bargman J; Bradley T; Silverman E
    Rheumatology (Oxford); 2009 May; 48(5):497-501. PubMed ID: 19269958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus.
    Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
    Rheumatol Int; 2018 Jun; 38(6):1053-1061. PubMed ID: 29302804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines as uremic toxins.
    Teta D
    J Ren Nutr; 2012 Jan; 22(1):81-5. PubMed ID: 22200420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical relevance of circulating immune complexes in patients with systemic lupus erythematosus and chronic polyarthritis].
    Menzel EJ; Smolen JS; Knapp W; Scherak O; Steffen C
    Acta Med Austriaca; 1979; 6(5):212-4. PubMed ID: 162334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
    Vogt B; Führnrohr B; Müller R; Sheriff A
    Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splanchnic concentrations and postprandial release of visceral adipokines.
    Wiest R; Moleda L; Farkas S; Scherer M; Kopp A; Wönckhaus U; Büchler C; Schölmerich J; Schäffler A
    Metabolism; 2010 May; 59(5):664-70. PubMed ID: 19913846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort.
    Alarcón-Segovia D; Alarcón-Riquelme ME; Cardiel MH; Caeiro F; Massardo L; Villa AR; Pons-Estel BA;
    Arthritis Rheum; 2005 Apr; 52(4):1138-47. PubMed ID: 15818688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.